Cullinan Therapeutics, Inc. · NASDAQ:CGEM

Lynx1 Capital Management LP reported a 9.80% stake in Cullinan Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Lynx1 Capital Management LP reported a 9.80% stake in Cullinan Therapeutics, Inc., 5,766,090 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
9.80%
Shares
5,766,090
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
LYNX1 CAPITAL MANAGEMENT LP9.80%5,766,090
WESTON NICHOLS9.80%5,766,090

Source

View original at SEC

Related